[go: up one dir, main page]

MX2018011121A - Prevención de la adherencia de tejido biológico. - Google Patents

Prevención de la adherencia de tejido biológico.

Info

Publication number
MX2018011121A
MX2018011121A MX2018011121A MX2018011121A MX2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A
Authority
MX
Mexico
Prior art keywords
biological tissue
self
tissue adhesion
assembling peptide
adhesion
Prior art date
Application number
MX2018011121A
Other languages
English (en)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of MX2018011121A publication Critical patent/MX2018011121A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

En la presente se describen métodos y materiales para mitigar la adherencia de tejidos biológicos. Un método para mitigar la adherencia a un tejido biológico incluye administrar una cantidad efectiva de una solución de péptido autoensamblante al tejido biológico, en donde el péptido autoensamblante tiene entre 7 aminoácidos y 32 aminoácidos de longitud, y la solución de péptido autoensamblante forma un hidrogel en condiciones fisiológicas.
MX2018011121A 2016-03-18 2017-03-17 Prevención de la adherencia de tejido biológico. MX2018011121A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (1)

Publication Number Publication Date
MX2018011121A true MX2018011121A (es) 2019-01-31

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011121A MX2018011121A (es) 2016-03-18 2017-03-17 Prevención de la adherencia de tejido biológico.

Country Status (11)

Country Link
US (4) US20190091376A1 (es)
EP (1) EP3429653B1 (es)
JP (1) JP7049557B2 (es)
KR (1) KR20190022455A (es)
CN (1) CN109152868A (es)
AU (2) AU2017232540A1 (es)
BR (1) BR112018068941A2 (es)
CA (1) CA3017684A1 (es)
CL (1) CL2018002646A1 (es)
MX (1) MX2018011121A (es)
WO (1) WO2017158420A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7049557B2 (ja) 2016-03-18 2022-04-07 株式会社スリー・ディー・マトリックス 生物組織の癒着の予防
WO2020008377A2 (en) 2018-07-03 2020-01-09 3-D Matrix, Ltd. Ionic self-assembling peptides
US11534528B2 (en) 2020-03-31 2022-12-27 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4023240A1 (en) * 2004-07-06 2022-07-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
AU2006241123B2 (en) * 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
ES2624484T3 (es) * 2008-10-06 2017-07-14 3-D Matrix, Ltd. Tapón de tejido
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
WO2014076660A1 (en) * 2012-11-14 2014-05-22 3-D Matrix Ltd. Vascular embolic system
US20160030628A1 (en) * 2013-03-14 2016-02-04 3-D Matrix, Ltd. Treatment for bile leakage
BR112018068939A2 (pt) 2016-03-18 2019-01-22 3 D Matrix Ltd oclusão de vazamento de fluido cérebro-espinhal
JP7049557B2 (ja) 2016-03-18 2022-04-07 株式会社スリー・ディー・マトリックス 生物組織の癒着の予防
US20200078489A1 (en) 2016-03-18 2020-03-12 3-D Matrix, Ltd. Pancreatic fistula occlusion

Also Published As

Publication number Publication date
BR112018068941A2 (pt) 2019-04-16
AU2017232540A1 (en) 2018-09-27
WO2017158420A1 (en) 2017-09-21
US20250177614A1 (en) 2025-06-05
AU2021225225A1 (en) 2021-09-30
US20220111126A1 (en) 2022-04-14
US20190091376A1 (en) 2019-03-28
CL2018002646A1 (es) 2019-07-05
US20230241294A1 (en) 2023-08-03
EP3429653A1 (en) 2019-01-23
KR20190022455A (ko) 2019-03-06
EP3429653B1 (en) 2022-11-09
CN109152868A (zh) 2019-01-04
CA3017684A1 (en) 2017-09-21
US12377196B2 (en) 2025-08-05
JP2019508184A (ja) 2019-03-28
JP7049557B2 (ja) 2022-04-07

Similar Documents

Publication Publication Date Title
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
EP4566651A3 (en) Ophthalmic delivery device
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
MX2018011120A (es) Oclusion de fistula pancreatica.
EP4349361A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
MX2018011121A (es) Prevención de la adherencia de tejido biológico.
HK1220145A1 (zh) 胆漏治疗
MX2021008207A (es) Proteínas de fusión multifuncionales y usos de las mismas.
WO2018068947A3 (de) Proteinhydrolysate
NZ751231A (en) Silk-derived protein for treating inflammation
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
EP3606570B8 (en) Collagen peptide-based medicament compositions for use in the treatment of ocular diseases, disorders or wounds
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
EP3590338A3 (en) Medical treatments based on anamorelin
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
AU2018236629A8 (en) Hydrogel patch
WO2019043649A3 (en) ANGIO -3 FOR THE TREATMENT OF RETINAL ANGIOGENIC DISEASES
MX2019005979A (es) Peptidos modificados.
WO2016073443A3 (en) Peripheral kappa opioid receptor agonists for hard tissue pain
ZA202002107B (en) Use of specific sirna against protein s for the treatment of hemophilia
MX2019000849A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
MX2018011201A (es) Oclusion de fuga de liquido cefalorraquideo.
EP4272830A3 (en) Tissue organoids
EP4257128A3 (en) Methods and compounds for the treatment of genetic disease